SCHEMBL6500546

SCHEMBL6500546

Cc1cc(OCc2ccccc2)c(Br)c(=O)[nH]1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 5/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CTSV O60911 2/20 0.42
CTSL P07711 2/20 0.42
POLB P06746 1/20 0.41
STAT3 P40763 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
MAOB P27338 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4508164 0.78 MAPK14 (0.49) MAPK14ALDH1A1KMT2AMAOB
SCHEMBL7436805 0.76 MAPT (0.56) MAPK14ALDH1A1L3MBTL1MAPTMAPK1
SCHEMBL4380696 0.74 MAPK14 (0.56) MAPK14
SCHEMBL4380048 0.74 MAPK14 (0.51) MAPK14ALDH1A1LMNAL3MBTL1MAPT
SCHEMBL16107102 0.73 CTSV (0.44) MAPK14ALDH1A1LMNACTSVCTSL
SCHEMBL31088870 0.72 MAPT (0.51) MAPK14ALDH1A1L3MBTL1MAPTMAPK1
SCHEMBL23258713 0.72 PTGER1 (0.48) MAPK14L3MBTL1MAPTMAPK1TDP1
SCHEMBL23259170 0.72 MAPT (0.47) MAPK14ALDH1A1LMNAL3MBTL1MAPT
SCHEMBL28352962 0.71 MAPT (0.44) ALDH1A1L3MBTL1MAPTMAPK1TDP1
SCHEMBL3420123 0.71 ALDH1A1 (0.48) ALDH1A1LMNAMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050176775-A1 Substituted pyridinones PHARMACIA CORPORATION 2005-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176775-A1 Substituted pyridinones MAPK1, MAPK6, MAP3K6 MAPK14 53/4885ALDH1A1 741/4885LMNA 1884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.